{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:04:38Z","timestamp":1767143078161,"version":"build-2238731810"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":4738,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s12603-011-0014-8","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T13:49:20Z","timestamp":1297864160000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A practical approach to lipid management in the elderly"],"prefix":"10.1016","volume":"15","author":[{"given":"A.","family":"Viljoen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12603-011-0014-8_bib1","unstructured":"World Health Organization. Top 10 causes of death [Fact sheet N\u00b0310]; updated October 2008 [cited January 2010] Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/index.html"},{"key":"10.1007\/s12603-011-0014-8_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.294.10.1255","article-title":"Trends in the leading causes of death in the United States, 1970\u20132002","volume":"294","author":"Jemal","year":"2005","journal-title":"JAMA"},{"key":"10.1007\/s12603-011-0014-8_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.amepre.2005.07.004","article-title":"Frailty, heart disease, and stroke: the Compression of Morbidity Paradigm","volume":"29","author":"Fries","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1007\/s12603-011-0014-8_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12603-011-0014-8_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.annepidem.2003.10.009","article-title":"Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis","volume":"14","author":"Anum","year":"2004","journal-title":"Ann Epidemiol"},{"key":"10.1007\/s12603-011-0014-8_bib7","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths","volume":"370","author":"Prospective Studies Collaboration.","year":"2007","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-126-10-199705150-00001","article-title":"Clarifying the direct relationship between total cholesterol and death from coronary heart disease in older persons","volume":"126","author":"Corti","year":"1997","journal-title":"Ann Inter Med"},{"key":"10.1007\/s12603-011-0014-8_bib9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/clinchem\/47.9.1579","article-title":"Evolution of Methods for Measurement of HDLCholesterol: From Ultracentrifugation to Homogeneous Assays","volume":"47","author":"Warnick","year":"2001","journal-title":"Clin Chem"},{"key":"10.1007\/s12603-011-0014-8_bib10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1007\/s12603-011-0014-8_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pmic.200300938","article-title":"Lipoproteomics I: mapping of proteins in low-density lipoprotein using two dimensional gel electrophoresis and mass spectrometry","volume":"5","author":"Karlsson","year":"2005","journal-title":"Proteomics"},{"key":"10.1007\/s12603-011-0014-8_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1373\/clinchem.2008.118356","article-title":"Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices","volume":"55","author":"Contois","year":"2009","journal-title":"Clin Chem"},{"key":"10.1007\/s12603-011-0014-8_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1007\/s12603-011-0014-8_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinchem\/38.1.150","article-title":"Measurement of low-density-lipoprotein cholesterol in serum: a status report","volume":"38","author":"Rifai","year":"1992","journal-title":"Clin Chem"},{"key":"10.1007\/s12603-011-0014-8_bib15","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report","volume":"106","author":"Third Report of the National Cholesterol Education Program","year":"2002","journal-title":"Circulation"},{"issue":"Suppl5","key":"10.1007\/s12603-011-0014-8_bib16","first-page":"v1","article-title":"JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice","volume":"91","author":"British Cardiac Society","year":"2005","journal-title":"Heart"},{"issue":"1","key":"10.1007\/s12603-011-0014-8_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJMe048326","article-title":"Statin for Atherosclerosis \u2014 As good as it gets?","volume":"352","author":"Ehrenstein","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1007\/s12603-011-0014-8_bib18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Cholesterol Treatment Trialists'","year":"2005","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib19","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group.","year":"1994","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"Cholesterol and Recurrent Events Trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-011-0014-8_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","author":"The Long-term Intervention with Pravastatin in Ischemic Disease","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-011-0014-8_bib22","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1161\/01.CIR.96.12.4211","article-title":"Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)","volume":"96","author":"Miettinen","year":"1997","journal-title":"Circulation"},{"key":"10.1007\/s12603-011-0014-8_bib23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.7326\/0003-4819-134-10-200105150-00007","article-title":"Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID Trial","volume":"134","author":"Hunt","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12603-011-0014-8_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group.","year":"2002","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib25","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.STR.0000254602.58896.d2","article-title":"Is it time for a primary prevention trial in the elderly?","volume":"38","author":"Robinson","year":"2007","journal-title":"Stroke"},{"key":"10.1007\/s12603-011-0014-8_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(07)60084-1","article-title":"Are clinical guidelines evidence based?","volume":"369","author":"Abramson","year":"2007","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib28","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1007\/s12603-011-0014-8_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1742-1241.2008.01721.x","article-title":"Enhanced LDL-C reduction: lower is better. Does it matter how?","volume":"62","author":"Viljoen","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1007\/s12603-011-0014-8_bib30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1742-1241.2008.01888.x","article-title":"Muddy waters: more stormy SEAS for ezetimibe","volume":"62","author":"Wierzbicki","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1007\/s12603-011-0014-8_bib31","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1001\/jama.292.21.2622","article-title":"Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis","volume":"292","author":"Psaty","year":"2004","journal-title":"JAMA"},{"key":"10.1007\/s12603-011-0014-8_bib32","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1007\/s12603-011-0014-8_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12603-011-0014-8_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198807073190105","article-title":"HMG-CoA reductase inhibitors for treatment of hypercholesterolemia","volume":"319","author":"Grundy","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-011-0014-8_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.mcg.0000155548.91524.6e","article-title":"Drug-induced hepatotoxicity","volume":"39","author":"Maddrey","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1007\/s12603-011-0014-8_bib36","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000013074.73995.6C","volume":"105","author":"Williams","year":"2002","journal-title":"Circulation"},{"key":"10.1007\/s12603-011-0014-8_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-8981(02)00188-2","article-title":"Reference measurement systems in clinical chemistry","volume":"323","author":"Thienpont","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1007\/s12603-011-0014-8_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jama.298.3.336","article-title":"Triglycerides and Risk for Coronary Heart Disease","volume":"298","author":"McBride","year":"2007","journal-title":"JAMA"},{"key":"10.1007\/s12603-011-0014-8_bib39","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/jc.2007-0275","article-title":"Update on dyslipidemia","volume":"92","author":"Garg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s12603-011-0014-8_bib40","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3748\/wjg.v9.i11.2622","article-title":"Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis","volume":"9","author":"Mao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1007\/s12603-011-0014-8_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI31608","article-title":"HDL proteomics: pot of gold or Pandora's box?","volume":"117","author":"Reilly","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1007\/s12603-011-0014-8_bib42","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk of coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Eng JMed"},{"key":"10.1007\/s12603-011-0014-8_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1368-5031.2006.00882.x","article-title":"FIELDS of dreams, fields of tears: a perspective on the fibrate trials","volume":"60","author":"Wierzbicki","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1007\/s12603-011-0014-8_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1185\/030079903125001668","article-title":"Statin-fibrate combination: therapy for hyperlipidemia: a review","volume":"19","author":"Wierzbicki","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1007\/s12603-011-0014-8_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1368-5031.2004.00233.x","article-title":"Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug","volume":"58","author":"Carlson","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1007\/s12603-011-0014-8_bib46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","author":"The Coronary Drug Project Research Group.","year":"1975","journal-title":"JAMA"},{"key":"10.1007\/s12603-011-0014-8_bib47","first-page":"e814","article-title":"Dosage and titration patterns of extended release niacin in clinical practice","volume":"113","author":"Kamal-Bahl","year":"2006","journal-title":"Circulation"},{"key":"10.1007\/s12603-011-0014-8_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1742-1241.2008.01967.x","article-title":"Resurrecting an old drug \u2014 a flash in the pan or here to stay?","volume":"63","author":"Viljoen","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1007\/s12603-011-0014-8_bib49","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1742-1241.2008.01868.x","article-title":"Cardiovascular risk estimation \u2014 making sense of the numbers","volume":"62","author":"Viljoen","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"20","key":"10.1007\/s12603-011-0014-8_bib50","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-011-0014-8_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"18","key":"10.1007\/s12603-011-0014-8_bib52","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s12603-011-0014-8_bib53","doi-asserted-by":"crossref","first-page":"b2376","DOI":"10.1136\/bmj.b2376","article-title":"The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials","volume":"338","author":"Brugts","year":"2009","journal-title":"BMJ"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-011-0014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-011-0014-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723024259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723024259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-011-0014-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:07:49Z","timestamp":1761138469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723024259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":53,"aliases":["10.1007\/s12603-010-0301-9"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1279770723024259"],"URL":"https:\/\/doi.org\/10.1007\/s12603-011-0014-8","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical approach to lipid management in the elderly","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-011-0014-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}